Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma

Metastatic renal cell carcinoma (mRCC) encompasses a heterogeneous group of neoplasms with distinct clinical behavior and prognoses. As a result of the increasing number of therapeutic options in the metastatic setting, it is crucial to improve prognostic stratification ability. We aimed to evaluate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pathology oncology research 2020-10, Vol.26 (4), p.2489-2497
Hauptverfasser:	Nader Marta, Guilherme, Isaacsson Velho, Pedro, Bonadio, Renata R. C., Nardo, Mirella, Faraj, Sheila F., de Azevedo Souza, Manoel Carlos L., Muniz, David Q. B., Bastos, Diogo Assed, Dzik, Carlos
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Cancer Research Immunology Inflammation Inhibitor drugs Kidney cancer Lymphocytes Medical prognosis Metastases Metastasis Multivariate analysis Neutrophils Oncology Original Article Pathology Patients Platelets Prognosis Renal cell carcinoma Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!